ArticleNature cancer2024

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

Evanthia T Roussos Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.